AAAAAA

   
Results: 1-11 |
Results: 11
HOW MUCH INFLAMMATORY BOWEL-DISEASE IS THERE - COMMENTARY
Authors: LANGMAN M
Citation: M. Langman, HOW MUCH INFLAMMATORY BOWEL-DISEASE IS THERE - COMMENTARY, The Italian Journal of Gastroenterology, 30(1), 1998, pp. 54-55
FLUORIDE RELEASE FOR EXPERIMENTAL AND COMMERCIAL MATERIALS
Authors: RIZKALLA AS JONES DW LANGMAN M
Citation: As. Rizkalla et al., FLUORIDE RELEASE FOR EXPERIMENTAL AND COMMERCIAL MATERIALS, Journal of dental research, 77, 1998, pp. 1090-1090
CHEMOPREVENTION OF COLORECTAL-CANCER
Authors: LANGMAN M BOYLE P
Citation: M. Langman et P. Boyle, CHEMOPREVENTION OF COLORECTAL-CANCER, Gut, 43(4), 1998, pp. 578-585
ARTHROPLASTY-DERIVED WEAR PARTICULATES AND BONE-MARROW DIFFERENTIATION IN-VITRO
Authors: ANDERSON G TAO LQ LANGMAN M
Citation: G. Anderson et al., ARTHROPLASTY-DERIVED WEAR PARTICULATES AND BONE-MARROW DIFFERENTIATION IN-VITRO, Journal of bone and mineral research, 12, 1997, pp. 647-647
OSTEOBLAST DIFFERENTIATION FROM RAT BONE-MARROW CELL-POPULATIONS IS ALTERED BY COCULTURE WITH PROSTATE OR BREAST-CARCINOMA CELL-LINES
Authors: ANDERSON GI TAO L LANGMAN M
Citation: Gi. Anderson et al., OSTEOBLAST DIFFERENTIATION FROM RAT BONE-MARROW CELL-POPULATIONS IS ALTERED BY COCULTURE WITH PROSTATE OR BREAST-CARCINOMA CELL-LINES, Journal of bone and mineral research, 12, 1997, pp. 692-692
RISING EMERGENCY ADMISSIONS
Authors: WEIL J LANGMAN M
Citation: J. Weil et M. Langman, RISING EMERGENCY ADMISSIONS, BMJ. British medical journal, 311(7019), 1995, pp. 1574-1574
PROPHYLACTIC ASPIRIN AND PEPTIC-ULCER BLEEDING - REPLY
Authors: LANGMAN M
Citation: M. Langman, PROPHYLACTIC ASPIRIN AND PEPTIC-ULCER BLEEDING - REPLY, BMJ. British medical journal, 311(6999), 1995, pp. 260-260
PROPHYLACTIC ASPIRIN AND RISK OF PEPTIC-ULCER BLEEDING
Authors: WEIL J COLINJONES D LANGMAN M LAWSON D LOGAN R MURPHY M RAWLINS M VESSEY M WAINWRIGHT P
Citation: J. Weil et al., PROPHYLACTIC ASPIRIN AND RISK OF PEPTIC-ULCER BLEEDING, BMJ. British medical journal, 310(6983), 1995, pp. 827-830
SEVERE CHICKENPOX DURING TREATMENT WITH CORTICOSTEROIDS - NATIONAL GUIDELINES EXIST
Authors: ELLENDER D WALLER P WOOD S RAWLINS M LANGMAN M SALISBURY D WILSON E
Citation: D. Ellender et al., SEVERE CHICKENPOX DURING TREATMENT WITH CORTICOSTEROIDS - NATIONAL GUIDELINES EXIST, BMJ. British medical journal, 310(6975), 1995, pp. 327-327
PROGNOSTIC FACTORS IN UPPER GASTROINTESTINAL-BLEEDING
Authors: KATSCHINSKI B LOGAN R DAVIES J FAULKNER G PEARSON J LANGMAN M
Citation: B. Katschinski et al., PROGNOSTIC FACTORS IN UPPER GASTROINTESTINAL-BLEEDING, Digestive diseases and sciences, 39(4), 1994, pp. 706-712
LACK OF EFFECT OF H-2-RECEPTOR ANTAGONISTS ON THE PHARMACOKINETICS OFALCOHOL CONSUMED
Authors: WALT RP KENDALL MJ BRAITHWAITE R LANGMAN M
Citation: Rp. Walt et al., LACK OF EFFECT OF H-2-RECEPTOR ANTAGONISTS ON THE PHARMACOKINETICS OFALCOHOL CONSUMED, Gastroenterology, 104(4), 1993, pp. 222-222
Risultati: 1-11 |